drugset / Trial / NCT04002141

Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis

NCT04002141 ↗

Phase 2 Completed 60 enrolled University of California, San Francisco
RandomizedParallel-groupSingle-blindPrevention

Summary

Randomized double blinded placebo-controlled trial to evaluate the impact of ovarian hyperstimulation on endometriosis-related symptoms and to evaluate the impact of letrozole use during ovarian hyperstimulation with respect to endometriosis-related symptoms, embryo/egg quality and quantity, and pregnancy rates.

Timeline

Start
2019-09-17
Primary completion
2023-10-01
Completion
2025-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 5 mg Oral